Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$25.26 - $29.6 $5.95 Million - $6.97 Million
235,388 New
235,388 $6.59 Million
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $5.15 Million - $5.96 Million
142,696 New
142,696 $5.23 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $3.31 Million - $4.04 Million
75,635 Added 89.7%
159,952 $7 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $2.93 Million - $3.48 Million
63,040 Added 296.28%
84,317 $4.42 Million
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $677,145 - $839,068
-14,801 Reduced 41.03%
21,277 $1.1 Million
Q4 2021

Feb 11, 2022

SELL
$41.32 - $61.25 $562,530 - $833,857
-13,614 Reduced 27.4%
36,078 $2.13 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $590,869 - $759,022
-15,054 Reduced 23.25%
49,692 $2.14 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $2.33 Million - $2.63 Million
64,746 New
64,746 $2.54 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $3.27 Million - $3.69 Million
-97,765 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $3.27 Million - $4.16 Million
97,765 New
97,765 $3.6 Million
Q3 2020

Nov 13, 2020

SELL
$31.75 - $37.25 $1.41 Million - $1.66 Million
-44,545 Closed
0 $0
Q2 2020

Aug 10, 2020

BUY
$30.12 - $36.54 $1.2 Million - $1.46 Million
39,990 Added 877.94%
44,545 $1.46 Million
Q1 2020

May 06, 2020

SELL
$27.03 - $38.62 $267,407 - $382,067
-9,893 Reduced 68.47%
4,555 $149,000
Q4 2019

Feb 26, 2020

SELL
$32.92 - $37.36 $706,660 - $801,969
-21,466 Reduced 59.77%
14,448 $566,000
Q4 2019

Feb 12, 2020

BUY
$32.92 - $37.36 $1.18 Million - $1.34 Million
35,914 New
35,914 $1.41 Million
Q1 2019

May 02, 2019

SELL
$37.5 - $41.2 $7,500 - $8,240
-200 Closed
0 $0
Q4 2018

Feb 08, 2019

BUY
$38.47 - $43.86 $7,694 - $8,772
200 New
200 $9,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Pearl River Capital, LLC Portfolio

Follow Pearl River Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pearl River Capital, LLC with notifications on news.